The Dow Jones today could lose 200 points after China warned about repercussions over U.S. efforts to stop shipments to Huawei.
That makes it an ugly morning for Apple (NASDAQ: AAPL), Qualcomm (NASDAQ: QCOM), Boeing (NYSE: BA), and Cisco (NASDAQ: CSCO).
In addition, Chinese officials may retaliate against White House efforts to stop Americans from putting Chinese stocks into their retirement accounts.
Here is everything moving the Dow today.
Stocks fell sharply today as investors continue to evaluate the United States' ability to reopen the economy.
The Dow, S&P 500, and Nasdaq all closed about 2% lower for the day as the volatility/fear index (VIX) spiked over 14%.
That's even on news that House Democrats unveiled their latest $3 trillion coronavirus relief bill…
Here's what our experts – Chris Johnson, D.R. Barton, Jr., and Shah Gilani – thought about the volatile move today, and which stocks investors should be focusing on to smooth out the bumps in their portfolios.
Stocks surged to close the week higher as investors think the worst of coronavirus is behind us.
That's even after the U.S. unemployment rate soared to 14.7%, the worst since the Great Depression.
Here's what our experts – Chris Johnson, D.R. Barton, Jr., and Shah Gilani – saw in the markets today.
And how they think investors should be positioning themselves heading into next week…
And how they think investors should be positioning themselves heading into next week...
The Dow jumped 260 points (1.1%) to close the week as oil extended its rebound from the negative $40 levels it touched Tuesday.
The June 2020 crude oil contracts are now trading for about $17, which is $53 higher than the -$40 number posted earlier in the week.
Despite the rebound, it's still down about 43% over the past two weeks.
Investors also weighed the possibility of Gilead Science Inc.'s (NASDAQ: GILD) new drug Remdesivir treating coronavirus patients.
It's to be seen whether it will be effective for the mass population or not…
Here's what our experts – Chris Johnson, Tom Gentile, D.R. Barton, Jr., and Shah Gilani – saw as we closed out another volatile week on Wall Street.
The Dow Jones popped this morning on news that a drug from Gilead Sciences (NASDAQ: GILD) showed some effectiveness in treating patients with coronavirus.
Shares of the drug company surged 16% after the bell on a report from a Chicago hospital that showed progress from Remdesivir.
Huge declines in year-over-year bank earnings were in focus on Wall Street this morning as some of the heavyweights reported before the opening bell.
The market opened down about 2% and closed near the same levels.
But that certainly isn't the only news you should be taking into account today…
You see, bank earnings have "knock-on effects" that can ripple throughout the economy in a variety of ways.
Here's what our experts – Chris Johnson, Tom Gentile, D.R. Barton, Jr., and Shah Gilani – saw in real time today, April 15
The Dow Jones is rising again as world governments respond to the coronavirus pandemic.
More on that, and other things you need to know to start your day...
The Dow Jones rallied 800 points at open today after a long week of coronavirus-induced volatility.
But there could be signs of stabilization ahead…
A slowdown in death rates across Europe has many people hoping the U.S. rate will peak soon.
Meanwhile, Japan has unveiled a new stimulus package worth 20% of GDP to help stave off negative economic impacts of the outbreak.
In order to help our Members navigate today's volatile markets, we started a brand-new live streaming service here at Money Morning.
Our experts – Chris Johnson, Tom Gentile, D.R. Barton, Jr., and Shah Gilani – are going to be with you every day that the markets are open.
They'll show you exactly what they're looking at and even give you some of the best trades to implement live.
Here's a brief recap of what they covered on Thursday, April 2...
by David Zeiler
It's clear the economic impact of the coronavirus crisis is creating challenges for most companies.
But for those companies that were struggling before the virus struck, life will be exponentially more difficult.
In particular, companies that were carrying a lot of debt and that were under scrutiny from the credit rating agencies will face a tougher road back to "normal" – if they can even get there.
Stay away from these five stocks right now...
